SCHEMBL2867415

SCHEMBL2867415

O=C(Nc1ccc2[nH]nc(-c3ccc4ccccc4c3)c2c1)C1CCNCC1

nearest known ligand 0.64

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ULK1 O75385 6/20 0.64
ITK Q08881 4/20 0.61
PDPK1 O15530 2/20 0.60
MAPK10 P53779 1/20 0.53
HTR1A P08908 2/20 0.52
HTR1D P28221 2/20 0.52
HTR2B P41595 2/20 0.52
HTR6 P50406 2/20 0.52
GSK3B P49841 1/20 0.50
MAPKAPK2 P49137 1/20 0.50
CLK2 P49760 1/20 0.49
CLK3 P49761 1/20 0.49
DYRK1A Q13627 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2871320 0.95 PDPK1 (0.66) ULK1ITKPDPK1MAPK10GSK3B
SCHEMBL2861621 0.88 PDPK1 (0.59) ULK1ITKPDPK1MAPK10GSK3B
SCHEMBL2861016 0.81 ITK (0.68) ITKMAPKAPK2
SCHEMBL2865036 0.81 PDPK1 (0.65) ULK1ITKPDPK1
Hydrochloric Acid SCHEMBL27396112 0.79 CYP1A2 (0.57) ULK1HTR1AHTR1DHTR2BHTR6
SCHEMBL8251891 0.78 ULK1 (0.61) ULK1ITKPDPK1GSK3BCLK2
SCHEMBL13854959 0.78 ULK1 (0.62) ULK1ITKPDPK1GSK3BCLK2
SCHEMBL8254064 0.78 ULK1 (0.59) ULK1ITKPDPK1
SCHEMBL14074986 0.78 GSK3B (0.56) PDPK1MAPK10GSK3B
SCHEMBL4338506 0.77 GSK3B (0.50) ITKPDPK1GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-6982274-B2 1H-indazole compound EISAI CO., LTD. (JP) 2006-01-03 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed
US-20040127538-A1 Novel 1h-indazole compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 ULK1 893/4885ITK 3726/4885PDPK1 885/4885
US-20040127538-A1 Novel 1h-indazole compound MAPK1, MAPK14, MAPK3 ULK1 1315/4885ITK 3628/4885PDPK1 1320/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 ULK1 893/4885ITK 3726/4885PDPK1 885/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.